126 related articles for article (PubMed ID: 32104492)
1. A cabazitaxel liposome for increased solubility, enhanced antitumor effect and reduced systemic toxicity.
Yin X; Luo L; Li W; Yang J; Zhu C; Jiang M; Qin B; Yuan X; Yin H; Lu Y; Du Y; Chen D; You J
Asian J Pharm Sci; 2019 Nov; 14(6):658-667. PubMed ID: 32104492
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer.
Zhuang B; Du L; Xu H; Xu X; Wang C; Fan Y; Cong M; Yin J; Li H; Guan H
Int J Pharm; 2016 Feb; 499(1-2):146-155. PubMed ID: 26762884
[TBL] [Abstract][Full Text] [Related]
3. Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy.
Liang H; Zou F; Liu Q; Wang B; Fu L; Liang X; Liu J; Liu Q
Int J Pharm; 2021 Apr; 599():120418. PubMed ID: 33647414
[TBL] [Abstract][Full Text] [Related]
4. Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects.
Kommineni N; Mahira S; Domb AJ; Khan W
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30934535
[TBL] [Abstract][Full Text] [Related]
5. A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect.
Zhou S; Li J; Yu J; Yang L; Kuang X; Wang Z; Wang Y; Liu H; Lin G; He Z; Liu D; Wang Y
Acta Pharm Sin B; 2021 Jan; 11(1):258-270. PubMed ID: 33532191
[TBL] [Abstract][Full Text] [Related]
6. Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes.
Tang WL; Tang WH; Chen WC; Diako C; Ross CF; Li SD
Mol Pharm; 2017 Jun; 14(6):1969-1979. PubMed ID: 28460165
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting Hypoxia and Chemotherapy-Induced Cancer Cell Metastasis under a Valid Therapeutic Effect by an Assistance of Biomimetic Oxygen Delivery.
Jiang MS; Yin XY; Qin B; Xuan SY; Yuan XL; Yin H; Zhu C; Li X; Yang J; Du YZ; Luo LH; You J
Mol Pharm; 2019 Nov; 16(11):4530-4541. PubMed ID: 31617723
[TBL] [Abstract][Full Text] [Related]
8. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
[TBL] [Abstract][Full Text] [Related]
9. Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer.
Qu N; Lee RJ; Sun Y; Cai G; Wang J; Wang M; Lu J; Meng Q; Teng L; Wang D; Teng L
Int J Nanomedicine; 2016; 11():3451-9. PubMed ID: 27555767
[TBL] [Abstract][Full Text] [Related]
10. Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy.
Liu J; Lee H; Huesca M; Young A; Allen C
Cancer Chemother Pharmacol; 2006 Sep; 58(3):306-18. PubMed ID: 16333677
[TBL] [Abstract][Full Text] [Related]
11. Improved antitumor activity and tolerability of cabazitaxel derived remote-loading liposomes.
Yang Z; Chi D; Wang Q; Guo X; Lv Q; Wang Y
Int J Pharm; 2020 Nov; 589():119814. PubMed ID: 32877728
[TBL] [Abstract][Full Text] [Related]
12. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
13. Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation.
Zhu C; Guo X; Luo L; Wu Z; Luo Z; Jiang M; Zhang J; Qin B; Shi Y; Lou Y; Qiu Y; You J
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46536-46547. PubMed ID: 31751119
[TBL] [Abstract][Full Text] [Related]
14. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Tanaka Y; Yamada S; Naito C; Yamamoto A
Biomaterials; 2018 Feb; 154():74-85. PubMed ID: 29120820
[TBL] [Abstract][Full Text] [Related]
15. A comparison study between lycobetaine-loaded nanoemulsion and liposome using nRGD as therapeutic adjuvant for lung cancer therapy.
Chen T; Gong T; Zhao T; Fu Y; Zhang Z; Gong T
Eur J Pharm Sci; 2018 Jan; 111():293-302. PubMed ID: 28966099
[TBL] [Abstract][Full Text] [Related]
16. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
17. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions.
Khoeeniha MK; Esfandyari-Manesh M; Behrouz H; Amini M; Varnamkhasti BS; Atyabi F; Dinarvand R
Curr Drug Deliv; 2017; 14(8):1120-1129. PubMed ID: 27875950
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Evaluation of in vitro Self-assembling HSA Nanoparticles for Cabazitaxel.
Qu N; Sun Y; Xie J; Teng L
Anticancer Agents Med Chem; 2017; 17(2):294-300. PubMed ID: 27225451
[TBL] [Abstract][Full Text] [Related]
19. Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer.
Hoang B; Ernsting MJ; Tang WS; Bteich J; Undzys E; Kiyota T; Li SD
Cancer Lett; 2017 Dec; 410():169-179. PubMed ID: 28965854
[TBL] [Abstract][Full Text] [Related]
20. Polymyxin E sulfate-loaded liposome for intravenous use: preparation, lyophilization, and toxicity assessment in vivo.
Wang D; Kong L; Wang J; He X; Li X; Xiao Y
PDA J Pharm Sci Technol; 2009; 63(2):159-67. PubMed ID: 19634354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
